Upcoming AWS Coverage on On Track Innovations Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. announces its post-earnings coverage on Steelcase Inc. (NYSE: SCS). The Company disclosed its fourth quarter and fiscal 2017 financial results on March 21, 2017. The office furniture maker surpassed revenue expectations. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Steelcase’s competitors within the Business Equipment space, On Track Innovations Ltd. (NASDAQ: OTIV), reported on March 22, 2017, its results for the fourth quarter and fiscal year ended December 31, 2016. AWS will be initiating a research report on On Track Innovations in the coming days.

Today, AWS is promoting its earnings coverage on SCS; touching on OTIV. Get our free coverage by signing up to

http://www.activewallst.com/register/

Earnings Reviewed

For the three months ended February 24, 2017, Steelcase reported revenue of $769.1 million, up 3% compared to revenue of $747.9 million in Q4 FY16. The Company’s revenue numbers surpassed analysts’ consensus of $$753 million.

On a geographical basis, Steelcase’s Americas segment posted revenue growth of 3%, which was negatively impacted by continued y-o-y declines in the energy sector. EMEA revenue declined 5%, or less than 1% on an organic basis. The Other category posted revenue growth of 13% in Q4 FY17 compared to prior year, driven by continued strength in Asia/Pacific.

Steelcase’s orders had increased by 6% in Q4 FY17. Order patterns were mixed during the reported quarter, growing by approximately 5% in the Americas and 24% in the Other category and declining by 3% in EMEA compared to the prior year. The order growth in the Americas was driven by project business, while orders related to continuing agreements and marketing programs declined in the quarter. The strong order growth in the Other category was driven by a record level of quarterly orders in Asia/Pacific.

For Q4 FY17, Steelcase’s operating income was $50.5 million compared to operating income of $25.8 million in Q4 FY16. Excluding restructuring costs, the Company’s adjusted operating income for the quarter increased by $21.4 million (or 270 basis points as a percentage of revenue) to $50.9 million.

For Q4 FY17, Steelcase’ net income totaled $25.8 million, or diluted earnings of $0.21 per share. During the reported quarter, as a result of a change in the French corporate tax rate, the Company reduced the value of its net deferred tax assets by approximately $8 million, which reduced diluted earnings per share by approximately $0.06, net of related variable compensation effects. On an adjusted basis, the Company posted earnings of $0.22 per share, which lagged behind Wall Street’s estimates of $0.23 per share.

Fiscal 2017 Results

For FY17, Steelcase posted revenue of $3.0 billion and net income of $124.6 million, or diluted earnings per share of $1.03. Adjusted earnings per share were $1.05. For FY16, the Company recorded revenue of $3.1 billion and net income of $170.3 million, or diluted earnings per share of $1.36. Adjusted earnings per share were $1.46 and included approximately $0.42 per share related to the significant items recorded during Q4 FY16.

The Americas and EMEA categories posted modest revenue declines, while the Other category posted revenue growth of 5%, driven largely by Asia/Pacific.

For FY17, Steelcase’s operating income was $200.2 million, or 6.6% of revenue, compared to operating income of $174.6 million, or 5.7% of revenue, for FY16. The Company’s adjusted operating income totaled $205.3 million, growing $10.8 million on a y-o-y basis.

Cash Matters

At the end of Q4 FY17, Steelcase’ total liquidity, comprising of cash, short-term investments and the cash surrender value of Company-owned life insurance, aggregated $439 million, and total debt was $297 million.

Steelcase’ Board of Directors has declared a quarterly cash dividend of $0.1275 per share, to be paid on or before April 14, 2017, to shareholders of record as of March 31, 2017. This represents an increase of $0.75 per share increase on a q-o-q basis.

Steelcase paid $59 million in dividends and repurchased 3 million shares under its share repurchase authorization program during fiscal 2017 at a cost of $42 million. The Company has $126.5 million remaining under its share repurchase authorization.

Outlook

Steelcase is forecasting Q1 FY18 revenue to be in the range of $725 million to $750 million, which reflects expected organic revenue growth of 2% to 6% over the prior year. The Company expects to report diluted earnings per share in the range of $0.13 to $0.17 for Q1 FY18.

Stock Performance

On Thursday, March 30, 2017, Steelcase’s share price finished yesterday’s trading session at $16.40, slipping 1.50%. A total volume of 544.62 thousand shares exchanged hands. The stock has rallied 18.61% and 13.48% in the last six months and past twelve months, respectively. The stock is trading at a PE ratio of 15.94 and has a dividend yield of 2.93%. At Thursday’s closing price, the stock’s net capitalization stands at $1.94 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458623

VANCOUVER, BC / ACCESSWIRE / March 31, 2017 / Kapuskasing Gold Corp. (TSX-V: KAP) (the “Company” or “KAP”) announces that the Company has signed a non-binding letter of intent to acquire The Jumbo Copper/Cobalt Property consisting of 76 claims (1900 hectares) contiguous to the recently announced Kings Court Property (see press release dated March 1, 2017). The Kings Court Copper/Cobalt property is now 2,275 hectares in size and covers at least 10 known copper/cobalt showings at surface, along with historic drilling, trenching and adits.

Kings Court: Significant exploration highlights of the property now includes the Jumbo showing where channel samples assayed 14% Cu over 3.0 m and 9.3% Cu over 10.0 m as well as a cobalt sample of up to 0.24%. As reported March 1, 2017, additional channel samples of 19% Cu over 2.13 metres and 15.87% Cu over 2.59 metres have been reported on the property, as well as a drill hole with 12.6% Cu over 1.52 metres and a chip sampling of 7.75% Cu over 2 metres.

The property now hosts at least 10 different Cu showings with significant surface results. Compilation of historic data will guide a detailed sampling program to evaluate the Co and Cu potential. The Kings Court Property is one of two priority projects (Lady Pond Project being the other) that the Company will focus its initial exploration efforts.

The Company has signed a non-binding letter of intent whereby KAP can purchase a 100% interest in the Jumbo Copper/Cobalt Property for total consideration of 650,000 shares, and a $3,000 one time cash payment. The Vendor shall retain a 2% net smelter royalty (NSR) interest. The Company retains the option to buy back 1% of the NSR for $1,000,000. A formal purchase agreement will follow upon completion of due diligence.

Mr. Garry Clark P.Geo,(Exploration Manager and a director of the Company) a Qualified Person (“QP”) as defined by National Instrument 43-101, has reviewed the technical content of this release. The content of the geological data presented has been derived from the Provinces Mineral Deposit Database and exploration assessment files and are believed to be accurate and correct.

On behalf of the Board of Directors

Kapuskasing Gold Corp.

Jonathan Armes
President & CEO
Phone 1 (416) 708-0243

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

This press release contains forward-looking statements within the meaning of applicable Canadian and U.S. securities laws and regulations, including statements regarding the future activities of the Company. Forward looking statements reflect the current beliefs and expectations of management and are identified by the use of words including “will”, “anticipates”, “expected to”, “plans”, “planned” and other similar words. Actual results may differ significantly. The achievement of the results expressed in forward-looking statements is subject to a number of risks, including those described in the Company’s management discussion and analysis as filed with the Canadian securities regulatory authorities which are available at www.sedar.com. Investors are cautioned not to place undue reliance upon forward-looking statements.

SOURCE: Kapuskasing Gold Corp.

ReleaseID: 458612

NEW YORK, NY / ACCESSWIRE / March 31, 2017 / Interpace Diagnostics Group Inc. (NASDAQ: IDXG) (“Interpace” or the “Company”), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, today announced that it will be presenting at this year’s MicroCap Conference on April 4th at 9 am ET in New York City.

CONFERENCE OVERVIEW AND STRUCTURE

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.

The MicroCap Conference will take place in New York City at the Essex House on April 4th. Registration will begin on Tuesday, April 4th, at 7:00 AM, and will last until the evening. These days will be jam-packed with company sessions, presentations, good food, and plenty of time to network with other investors over drinks at the reception. This event does not allow service providers – only portfolio managers, analysts, and private investors.

REGISTRATION FOR INVESTORS

To register, please go to our website (www.microcapconf.com) and click “Register.”

PARTICIPATING COMPANIES

For our most updated list of companies, please go to our website (http://microcapconf.com/conferences/new-york-2017/).

MARQUEE SPONSORS

The Special Equities Group
Maxim Group

About Interpace Diagnostics Group, Inc.

Interpace is a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for better patient diagnosis and management. The Company currently has three commercialized molecular tests: PancraGEN®, for the evaluation of pancreatic cysts and assessment of risk of concomitant or subsequent cancer; ThyGenX®, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay; and ThyraMIR®, for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay. Interpace’s mission is to provide personalized medicine through molecular diagnostics and innovation to advance patient care based on rigorous science. For more information, please visit Interpace Diagnostics’ website at www.interpacediagnostics.com.

News Compliments of ACCESSWIRE.

FOR MORE INFORMATION

Please visit: www.microcapconf.com.

Or, contact Tony Yu at tony@microcapconf.com.

SOURCE: Interpace Diagnostics Group Inc.

ReleaseID: 458485

Upcoming AWS Coverage on PulteGroup

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. announces its post-earnings coverage on Lennar Corp. (NYSE: LEN). The Company announced its first quarter fiscal 2017 results on March 21, 2017. The Homebuilder outperformed top- and bottom-line expectations. On February 10, 2017, Lennar completed its acquisition of WCI. Register with us now for your free membership at:

http://www.activewallst.com/register/

One of Lennar’s competitors within the Residential Construction space, PulteGroup, Inc. (NYSE: PHM), is estimated to report earnings on April 20, 2017. AWS will be initiating a research report on PulteGroup following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on LEN; touching on PHM. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

For its first quarter ended February 28, 2017, Lennar recorded revenue of $2.34 billion compared to revenue of $1.99 billion in Q1 FY16. The Company’s reported numbers topped analysts’ consensus of $2.17 billion.

For Q1 FY17 net earnings attributable to Lennar were $130.8 million, or $0.56 per diluted share, which included a net loss related to WCI of $0.03 per diluted share. This compared to Q1 FY16 net earnings attributable to Lennar were $144.1 million, or $0.63 per diluted share. On an adjusted basis, the Company posted earnings of $0.59 per share which exceeded Wall Street’s estimates for earnings of $0.56 per share.

Lennar Homebuilding revenues from home sales increased 13% in Q1 FY17 to $2.0 billion compared to $1.8 billion in Q1 FY16. Revenues were higher primarily due to a 13% increase in the number of home deliveries, excluding unconsolidated entities. New home deliveries, excluding unconsolidated entities, increased to 5,433 homes in the reported quarter from 4,806 homes in the year ago comparable period.

The average sales price of homes delivered was $365,000 in Q1 FY17, consistent with the Q1 FY16. Sales incentives offered to homebuyers were $22,700 per home delivered in the reported quarter, or 5.9% as a percentage of home sales revenue, compared to $21,600 per home delivered in the year earlier same quarter, or 5.6% as a percentage of home sales revenue, and $23,700 per home delivered in Q4 FY16, or 6.2% as a percentage of home sales revenue.

For Q1 FY17, gross margins on home sales were $419.2 million, or 21.1% compared to $398.9 million, or 22.7%, in Q1 FY16. Gross margin percentage declined primarily due to an increase in land and construction costs per home. Gross profits on land sales were $2.0 million in Q1 FY17 compared to $9.2 million in Q1 FY16.

Lennar Homebuilding interest expense was $52.4 million in Q1 FY17, where $48.7 million was included in costs of homes sold, $2.4 million in costs of land sold, and $1.2 million in other income (expense) compared to $45.2 million in Q1 FY16 where $43.4 million was included in costs of homes sold, $0.7 million in costs of land sold, and $1.2 million in other income (expense).

Lennar Financial Services

Operating earnings for the Lennar Financial Services segment were $20.7 million in Q1 FY17 compared to $14.9 million in Q1 FY16. The increase in profitability was primarily due to increased volume and profitability in the segment’s title operations.

Operating earnings for the Rialto segment were $12.0 million in Q1 FY17 which included a $0.8 million operating loss and an add back of $12.9 million of net loss attributable to non-controlling interests. Operating earnings in Q1 FY16 were $1.9 million which included $1.6 million of operating earnings and an add back of $0.3 million of net loss attributable to non-controlling interests. The increase in operating earnings is primarily related to an increase in Rialto Mortgage Finance earnings as a result of higher securitization volume and margins, partially offset by an increase in general and administrative expenses, loan impairments, and real estate owned impairments.

Lennar Multifamily

Operating earnings for the Lennar Multifamily segment were $19.2 million in Q1 FY17 compared to $12.2 million in Q1 FY16. The increase in profitability was primarily due to the segment’s $26.0 million share of gains related to the sale of two operating properties by Lennar Multifamily’s unconsolidated entities in the reported quarter compared to the segment’s $20.4 million share of a gain as a result of the sale of one operating property by one of its unconsolidated entities in the prior year’s same quarter.

Debt Issuance

During Q1 FY17, Lennar issued $600 million aggregate principal amount of 4.125% senior notes due 2022. The Company used the net proceeds from the sale of the 4.125% Senior Notes to fund a portion of the cash consideration for its acquisition of WCI, to pay costs and expenses related to the acquisition of WCI and for general corporate purposes.

Stock Performance

On Thursday, March 30, 2017, the stock closed the trading session at $51.30, slightly dropping 0.39% from its previous closing price of $51.50. A total volume of 1.58 million shares have exchanged hands. Lennar’s stock price rallied 2.58% in the last month, 18.96% in the past three months, and 18.96% in the previous six months. Furthermore, since the start of the year, shares of the Company have surged 19.60%. The stock is trading at a PE ratio of 13.09 and has a dividend yield of 0.31%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458621

Upcoming AWS Coverage on BeiGene Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. blog coverage looks at the headline from Lexington based Agenus Inc. (NASDAQ: AGEN) as the Company announced on March 31, 2017, that it is reorganizing its business and operations to focus on clinical development of its two checkpoint inhibitor antibodies and vaccine program. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

One of Agenus’ competitors within the Biotechnology space, BeiGene, Ltd. (NASDAQ: BGNE), reported on March 22, 2017, its business highlights and financial results for Q4 and full year of 2016. AWS will be initiating a research report on BeiGene in the coming days.

Today, AWS is promoting its blog coverage on AGEN; touching on BGNE. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/.

The Company plans to close its Basel, Switzerland site and consolidate key functions to its Cambridge, UK and Lexington, MA facilities, and phase out approximately 50 positions across the organization, or approximately 20% of its employee strength, within the next six months. Additionally, Agenus announced that Robert Stein, M.D., Ph.D., President of R&D, will retire to become a senior R&D advisor exclusive to Agenus.

Agenus’ stated that through the realignment, the Company plans to accelerate development and commercialization of its product portfolio to drive shareholder value. Agenus stated that it would like to further extend the Company’s cash runway beyond the impact from the recently amended Incyte partnership, which strengthened the balance sheet by $80 million and reduced development expenses. Agenus noted that the restructuring will consolidate operations to improve R&D efficiencies and also ensure commercial readiness and manufacturing.

Focus on Key Programs

Agenus announced that its prioritized programs include combination therapies targeting CTLA-4 and PD-1. Additionally, Agenus will continue to drive its innovative immuno-oncology portfolio towards clinical development with two preclinical antibodies targeting 4-1BB and TIGIT, as well as AutoSynVax™, a clinical-stage neoantigen cancer vaccine. The Company is exploring combination studies with AutoSynVax and Agenus’ checkpoint antibodies. As part of the restructuring, some posts are planned to be phased out. In addition, the Company will transition or consolidate certain key management positions, with the objective of streamlining leadership and reducing costs.

“These changes to our organizational structure make us a leaner and more focused organization, which is critically important for our next phase of advancement towards commercial readiness. We will also maintain a focused R&D effort to rapidly generate and develop best of breed novel immuno-oncology candidates. It is important to indicate that as an agile and efficient company we aim to rapidly deliver effective treatments at affordable prices,” commented Dr. Armen, the Company’s Chairman.

Agenus announced that Dr. Robert Stein, who was instrumental in building R&D capability for Agenus and spearheaded the advancement of five programs from discovery to clinical stage in the last three years, will be retiring from his current role as President of R&D and will become a senior R&D advisor to Agenus. The current R&D leadership, which has been assembled under his tutelage, will continue to have access to Dr. Stein for strategic R&D guidance.

Stock Performance

At the close of trading session on Thursday, March 30, 2017, Agenus’ stock price dropped 2.04% to end the day at $3.84. A total volume of 1.40 million shares were exchanged during the session, which was above the 3-month average volume of 1.19 million shares. The stock currently has a market cap of $337.50 million.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458651

Upcoming AWS Coverage on ACI Worldwide Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. blog coverage looks at the headline from VMware, Inc. (NYSE: VMW) as the leading cloud infrastructure and business Company announced on March 30, 2017, that it has entered into a Stock Purchase Agreement with Dell Technologies, Inc. (NYSE: DVMT) under which VMware will purchase $300 million worth of VMware Class A Common Stock currently held by a Dell’s subsidiary. This $300 million Stock Purchase Agreement is a part of the Company’s previously announced buyback authorization through the end of FY18. Register with us now for your free membership and blog access at: http://www.activewallst.com/register/.

One of VMware’s competitors within the Technical & System Software space, ACI Worldwide, Inc. (NASDAQ: ACIW), reported on March 02, 2017, its financial results for the quarter and full year ended December 31, 2016. AWS will be initiating a research report on ACI Worldwide in the coming days.

Today, AWS is promoting its blog coverage on VMW and DVMT; touching on ACIW. Get all of our free blog coverage and more by clicking on the link below: http://www.activewallst.com/register/.

Breaking down the transaction

The purchase price per share is fixed at a 3.5% discount to a volume-weighted average stock price of VMware’s Class A Common stock based on trading on the NYSE during a reference period, which will not be greater than 25% higher or 25% lower than the closing price per share on March 31, 2017. The trading of shares is being carried out with EMC Equity Assets LLC, a Dell’s wholly owned subsidiary, at an initial closing expected to occur on April 05, 2017, which is subject to customary closing conditions.

VMware will deliver the Purchase Amount to EMC in exchange for an initial delivery of shares. A final closing is expected to occur post three business days at the end of the reference period, during VMware’s Q2 FY18, ending August 04, 2017. At the final closing, EMC will deliver VMware a number of shares necessary to fulfill the initial agreement where the final amount will be $300 million divided by the Purchase Price minus the number of Shares delivered at the initial closing.

The December $500 Million Repurchase

Prior to this agreement, VMware initially entered into a Stock Purchase Agreement with Dell Technologies under which, it purchased $500 million worth of VMware Class A Common Stock, held by EMC Corporation, on December 15, 2016. The $500 million stock purchase was expected to be completed during VMware’s Q1 FY18. Dell Technologies separately announced that it plans to use the $500 million proceeds to repurchase the Dell tracking stock for VMware, DVMT, as described in its announcement made on December 15, 2016.

VMware’s Growth Portfolio

VMware has been executing a strategic collaboration with leading technology conglomerates in recent quarters. Just yesterday, on March 29, 2017, the Company announced an expansion of its strategic collaboration with Fujitsu to bring innovative IoT solutions to customers in the automobile industry. VMware, being an industry leader in its fields, enables customers to add to the scale of their digital transformation. Under this agreement, Fujitsu OTA Reprogramming Solution was combined with VMware IoT solutions, enabling automobile manufacturers and partners to drive robust solutions in the future with connected cars and autonomous driving.

Additionally, it announced an extended partnership with Samsung on March 29, 2017, to deliver a next generation unified mobile and desktop experiences to solve mobile workforce challenges. The VMware Horizon and Samsung Desktop Experience will reportedly enable end-users to dock a Samsung Galaxy S8 smartphone and deliver to the device full Windows desktops and applications using a single set of credentials.

Stock Performance

On Thursday, March 30, 2017, the stock closed the trading session at $91.42, slightly down 0.46% from its previous closing price of $91.84. A total volume of 1.26 million shares have exchanged hands. VMware’s stock price advanced 15.04% in the last three months, 23.79% in the past six months, and 74.77% in the previous twelve months. Furthermore, on a year to date basis, the stock gained 16.12%. Shares of the company have a PE ratio of 32.59. The net market capital for the Company was $37.12 billion.

On March 30, 2017, the stock of Dell ended the trading session at $63.99, advancing slightly by 0.14%. A total volume of 2.59 million shares was exchanged. The stock has advanced 15.63% in the last quarter and 33.70% in the last six months. Moreover, the stock has surged 16.41% since the start of the year. The net market capital for the Company stood at $13.77 billion based on Thursday’s closing price.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458649

Upcoming AWS Coverage on Primo Water Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. announces its post-earnings coverage on Coca-Cola European Partners PLC (NYSE: CCE) (“CCEP”). The Company posted its financial results for the fourth quarter fiscal 2016 (Q4 FY16) and full year 2016 (FY16) on March 21, 2017. The London, UK-based Company’s quarterly net sales and profit after taxes increased on a year-over-year basis. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of Coca-Cola European Partners’ competitors within the Beverages – Soft Drinks space, Primo Water Corp. (NASDAQ: PRMW), reported on March 15, 2017, its financial results for Q4 and full year ended December 31, 2016. AWS will be initiating a research report on Primo Water following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on CCE; touching on PRMW. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

In Q4 FY16, CCEP’s net sales surged 73.0%, due to inclusion of Germany and Iberia business in the Company’s business portfolio in FY16. Meanwhile, pro-forma comparable revenue during Q4 FY16 was €2.58 billion compared to €2.57 billion reported in Q4 FY15.

The independent Coca-Cola bottler reported pro-forma comparable profit after taxes of €212 million, or €0.43 per diluted share, in Q4 FY16 compared to €179 million, or €0.37 per diluted share, in Q4 FY15.

For full year FY16, CCEP’s pro-forma comparable net sales were €10.87 billion compared to €11.04 billion reported in FY15. The Company reported pro-forma comparable profit after taxes of €938 million, or €1.92 per diluted share, in FY16 compared to €831 million, or €1.70 per diluted share, in FY15.

Operating Metrics

During Q4 FY16, CCEP’s pro-forma comparable cost of sales came relatively flat at €1.56 billion. The Company’s pro-forma comparable gross profit was €1.02 billion in Q4 FY16 compared to €1.01billion in previous year’s same quarter. The Company incurred pro-forma comparable operating expenses of €691 million in Q4 FY16 versus €707 million in Q4 FY15. In the reported quarter, pro-forma comparable operating profit increased to €327 million from €305 million in Q4 FY15. Furthermore, the pro-forma comparable profit before taxes during Q4 FY16 came in at €290 million compared to €265 million in the previous year’s same quarter.

In Q4 FY16, the Company’s pro-forma comparable volume increased to 603million of unit cases from 595 million of unit cases in Q4 FY15. Additionally, revenue per unit case in Q4 FY16 was €4.44 versus €4.38 in last year’s comparable quarter.

Cash Flow & Balance Sheet

During the year ended December 31, 2016, CCEP’s operating activities provided net cash of €1.24 billion compared to €922 million in the year ago same period. The Company had cash and cash equivalents balance of €386 million as on December 31, 2016, compared to €156 million at the close of books on December 31, 2015. Furthermore, the Company’s non-current borrowings increased to €5.56 billion as on December 31, 2016, from €3.12 billion as on December 31, 2015.

Dividend

In its earnings press release, CCEP’s Board of Directors declared regular quarterly dividend of €0.21 per share. The dividend is payable April 24, 2017, to those shareholders of record on April 10, 2017.

Outlook

In its guidance for full year FY17, CCEP’s management affirmed the prior guidance of modest low single-digit revenue growth along with up to high single-digits growth in operating profit and diluted earnings per share. Meanwhile, excluding synergies, the Company expects core operating profit growth is expected to modestly exceed revenue growth in FY17.

The Company expects free cash flow in a range of €700 million to €800 million in FY17, which will include the expected benefit from improved working capital offset by the impact of restructuring and integration costs. Capital expenditures during FY17 are projected to be in a range of €575 million to €625 million, including €75 million to €100 million of capital expenditures related to synergies. Furthermore, the Company does not intend to repurchase shares in FY17.

Stock Performance

At the closing bell, on Thursday, March 30, 2017, Coca-Cola European Partners’ stock rose slightly by 0.13%, ending the trading session at $37.70. A total volume of 1.37 million shares were traded at the end of the day. In the last month and previous three months, shares of the Company have advanced 9.31% and 19.23%, respectively. Moreover, the stock surged 20.06% since the start of the year. The Company’s shares are trading at a PE ratio of 24.20 and have a dividend yield of 1.88%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458643

Upcoming AWS Coverage on Boeing

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. announces its post-earnings coverage on AAR Corp. (NYSE: AIR). The Company reported its third quarter fiscal 2017 results on March 21, 2017. The airplane maintenance Company met earnings expectations and outperformed revenue expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of AAR Corp.’s competitors within the Aerospace/Defense Products & Services space, The Boeing Co. (NYSE: BA), is estimated to report earnings on April 26, 2017. AWS will be initiating a research report on Boeing following the release of its next earnings results.

Today, AWS is promoting its earnings coverage on AIR; touching on BA. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

For the three months ended February 28, 2017, AAR reported consolidated sales of $446.7 million. For Q3 FY16, the Company reported sales of $412.1 million. AAR’s revenue numbers surpassed analysts’ consensus of $422 million.

For Q3 FY17, AAR’s selling, general, and administrative expenses as a percentage of sales were 10.6% compared to 10.5% in the year earlier quarter. During the reported quarter, the Company incurred approximately $1.4 million in legal fees related to its defense of the INL/A Aviation Support Services Contract awarded by the US Department of State (“DoS”) on September 01, 2016 and protested by the incumbent. The US Government Accountability Office reaffirmed the award on December 23, 2016, and the incumbent filed a second protest with the US Court of Federal Claims (“COFC”) on December 28, 2016.

AAR’s net interest expense from continuing operations for Q3 FY17 was $1.4 million compared to $1.6 million last year. Also, during the reported quarter, the Company paid cash dividends of $2.5 million, or $0.075 per share.

AAR reported income from continuing operations of $13.1 million, or $0.38 per diluted share, compared to income from continuing operations of $9.9 million, or $0.29 per diluted share. Earnings, adjusted to account for discontinued operations, were $0.38 per share. The Company’s earnings numbers met market expectations of $0.38 per share.

Sales Numbers

For Q3 FY17, AAR’s sales in Aviation Services increased 9.6% reflecting continued strong performance for the Company’s industry leading supply chain management solutions. Sales in Expeditionary Services also increased 1.6% as volumes continue to recover in the mobility business.

During Q3 FY17, AAR announced significant new business wins in the reported quarter including the award of a comprehensive supply chain management and component repair agreement with Allegiant Air covering their fleet of A320 aircraft and an agreement to provide landing gear overhaul and exchange services for SkyWest’s fleet of Bombardier CRJ aircraft. Subsequent to the end of the reported quarter, the Company signed a five year agreement with India’s largest airline, Interglobe Aviation Limited (IndiGo), to provide landing gear overhaul services on up to 49 full ship sets of A320 landing gear.

AAR’s Q3 FY17 sales to commercial customers represented 68.1% of consolidated sales compared to 60.6% of consolidated sales in Q3 FY16. Sales to government and defense customers represented 31.9% of consolidated sales in the reported quarter compared to 39.4% in the prior year’s same quarter.

Balance Sheet

AAR’s net debt at February 28, 2017, was $162.7 million compared to $145.3 million at February 29, 2016. The net debt increase during the reported quarter was primarily for investments in assets to support the Company’s recently announced long-term flight hour program awards. AAR’s CapEx in Q3 FY17 was $9.1 million. During the reported quarter, the Company paid dividends of $2.5 million, or $0.075 a share, and repurchased approximately 52,000 shares in the open market for $1.7 million. As of the end of the quarter, AAR had $66.1 million remaining available under its Board authorized share repurchase plan.

Stock Performance

At the close of trading session on Thursday, March 30, 2017, AAR Corp.’s share price finished yesterday’s trading session at $33.78, slightly falling 0.38%. A total volume of 121.91 thousand shares exchanged hands. The stock has surged 13.93% and 46.76% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have gained 2.45%. The stock is trading at a PE ratio of 25.17 and has a dividend yield of 0.89%.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458641

Upcoming AWS Coverage on Cotiviti Holdings Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 31, 2017 / Active Wall St. announces its post-earnings coverage on HealthEquity, Inc. (NASDAQ: HQY). The Company released its fourth quarter and fiscal 2017 results on March 21, 2017. The provider of services for managing health care exceeded top- and bottom-line expectations. Register with us now for your free membership at: http://www.activewallst.com/register/.

One of HealthEquity’s competitors within the Healthcare Information Services space, Cotiviti Holdings Inc. (NYSE: COTV), reported on February 22, 2017, its financial results for the three months and year ended December 31, 2016. AWS will be initiating a research report on Cotiviti in the coming days.

Today, AWS is promoting its earnings coverage on HQY; touching on COTV. Get our free coverage by signing up to:

http://www.activewallst.com/register/

Earnings Reviewed

For the fourth quarter ended January 31, 2017, HealthEquity reported revenue of $46.8 million, an increase of 30% compared to $35.9 million for the fourth quarter ended January 31, 2016. The Company’s revenue surpassed analysts’ consensus of $45.0 million.

HealthEquity’s revenue comprised of Service revenue of $20.6 million, an increase of 21% on a y-o-y basis, custodial revenue of $16.0 million, an increase of 44% compared to Q4 FY16 and interchange revenue of $10.1 million, an increase of 33% compared to Q4 FY16. For FY17, HealthEquity reported revenue of $178.4 million, up 41% compared to $126.8 million for FY16.

HealthEquity’s non-GAAP adjusted EBITDA was $11.8 million for Q4 FY17, an increase of 33% compared to $8.9 million for Q4 FY16. The Company’s non-GAAP adjusted EBITDA surged 55% to $62.8 million for FY17 compared to $40.6 million for FY16. HealthEquity’s adjusted EBITDA was 35% of revenue for FY17 compared to 32% for FY16.

For Q4 FY17, HealthEquity’s net income was $4.1 million, or $0.07 per diluted share, compared to $3.1 million, or $0.05 per diluted share, for Q4 FY16. The Company’s revenue number surpassed market estimates of $0.05 per share. For FY17, HealthEquity’s net income was $26.4 million, or $0.44 per share, compared to $16.6 million, or $0.28 per share.

HSA Member and Custodial asset metrics

As of January 31, 2017, the total number of HSAs for which HealthEquity serve as a non-bank custodian were 2.7 million, an increase of 28% from 2.1 million as of January 31, 2016. Total Custodial Assets as of January 31, 2017, was $5.0 billion, an increase of 37% year-over-year, consisting of Custodial Cash Assets of $4.4 billion, an increase of 34% compared to Q4 FY16 and Custodial Investment Assets of $658.6 million, an increase of 62% compared to Q4 FY16.

Outlook

For the year ended January 31, 2018, HealthEquity is forecasting revenue in the range of $220.0 million and $225.0 million. The Company expects net income to be in the band of $30.0 million to $34.0 million, resulting in a net income per diluted share range of $0.50 to $0.55. HealthEquity’s adjusted EBITDA outlook is a range of $77.0 million to $82.0 million. The business outlook for the year ended January 31, 2018, assumes a projected effective income tax rate of approximately 37%.

As of January 31, 2017, we had $180.4 million of cash, cash equivalents, and marketable securities and no outstanding debt. This compared to $123.8 million in cash, cash equivalents, and marketable securities and no outstanding debt as of January 31, 2016.

Stock Performance

On Thursday, March 30, 2017, HealthEquity’s share price finished yesterday’s trading session at $40.84, climbing 2.02%. A total volume of 384.04 thousand shares exchanged hands. The stock has soared 8.07% and 65.55% in the last six months and past twelve months, respectively. Furthermore, since the start of the year, shares of the Company have gained 0.79%. The Company’s shares are trading at a P/E of 92.61. At Thursday’s closing price, the stock’s net capitalization stands at $2.55 billion.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458645

The Moving Film will Help Bring Awareness and Support to the Humanitarian Issues that are Facing the People of Mozambique, Africa

LOS ANGELES, CA / ACCESSWIRE / March 31, 2017 / Carla and Ted Chandler are pleased to announce the upcoming launch of their film VALUE/ABLE, a documentary on Mozambique.

To watch a short video about VALUE/ABLE and learn more about the Chandlers and their reason for creating this poignant and educational documentary, please check out https://goo.gl/8VQMSU at any time.

As a spokesperson for VALUE/ABLE noted, the Chandlers are devoted to creating a documentary that shows the issues Mozambique is currently facing, as well as offer solutions that will lead to real change.

“This is a story of resilience, compassion and dedication to the human spirit. It will not be your typical, brow-beating, condescending ‘look at all the poor children in Africa’ films we have all seen growing up,” the spokesperson said, adding that while Mozambique is one of the poorest countries in the world and people do live with poverty, hunger and HIV, the Chandlers also want to tell the story of the country’s vast amount of human resilience.

As a daughter of missionary parents, Carla has been involved with Mozambique for over four years; she has personally travelled to Africa and has seen the needs of its people with her own eyes. Since Carla’s first visit, she has devoted her life’s work to helping the people of Africa by raising thousands of dollars in funds and hundreds of items in donations such as clothes, blankets and basic living necessities.

Ted is an Emmy award winning filmmaker and winner of the best short film at the prestigious New York Film Festival. With over 20 years of making quality television, short films and feature documentaries, he is uniquely qualified to tell the story of the people in Mozambique.

Working together, Carla and Ted have the experience, interest and passion that are necessary to create a moving and impactful documentary about Mozambique.

In order to help pay for the many costs associated with filming VALUE/ABLE, the Chandlers recently launched a fundraiser on Kickstarter. There, they hope to raise $60,000 through crowdfunding.

“We want to provide a tool through this film to educate and motivate change for these people,” the Chandlers said.

About VALUE/ABLE:

VALUE/ABLE is an upcoming documentary on Mozambique, Africa. The film will tell a moving story about resilience, compassion and dedication to the human spirit. For more information, please visit https://goo.gl/8VQMSU.

Contact:

Essie Clayton
admin@rocketfactor.com
(949) 555-2861

SOURCE: VALUE/ABLE

ReleaseID: 458656